Home › Funds › Soleus Capital Management, L.P. › ALKS
Soleus Capital Management, L.P. position in ALKS
ALKERMES PLC · Health Care
Soleus Capital Management, L.P. reported holding 1,029,252 shares of ALKS (ALKERMES PLC) in its Q2 2026 13F filing — a position valued at US$53.9M, representing 1.86% of its reported portfolio and ranking #14 among its reported holdings. Soleus Capital Management, L.P. has disclosed ALKS holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s ALKS position evolved
Soleus Capital Management, L.P. first disclosed a stake in ALKS in Q3 2023 at 54,400 shares (US$1.5M). The position peaked in Q1 2026 at 1,970,864 shares, worth US$69.7M. Across 4 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,029,252 shares valued at US$53.9M — a reduction of -941,612 shares quarter over quarter.. Notable position changes include a 49% increase in Q1 2026 (shares rose 48% over the following quarter), a 48% trim in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 54.40K | $1.52M | New |
| Q4 2025 | 1.32M | $37.00M | New |
| Q1 2026 | 1.97M | $69.69M | Add |
| Q2 2026 | 1.03M | $53.93M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 42 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$338.5M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.46M sh · $338.52M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held ALKS?
Soleus Capital Management, L.P. has disclosed ALKS holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in ALKS?
As of Q2 2026, Soleus Capital Management, L.P. holds 1.03M shares of ALKS (ALKERMES PLC), valued at $53.93M, representing 1.86% of its reported portfolio and ranking #14.
Has Soleus Capital Management, L.P. been buying or selling ALKS?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in ALKS. The position peaked in Q1 2026 at 1.97M shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.